位置:首页 > 蛋白库 > KHPB_STRR6
KHPB_STRR6
ID   KHPB_STRR6              Reviewed;         328 AA.
AC   Q8CY87;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 102.
DE   RecName: Full=RNA-binding protein KhpB {ECO:0000255|HAMAP-Rule:MF_00867};
DE   AltName: Full=Elongasome regulating protein {ECO:0000303|PubMed:28710862};
DE            Short=EloR {ECO:0000303|PubMed:28710862};
DE   AltName: Full=KH-domain protein B {ECO:0000305};
DE   AltName: Full=RNA-binding protein EloR {ECO:0000255|HAMAP-Rule:MF_00867};
DE   AltName: Full=RNA-binding protein Jag {ECO:0000303|PubMed:27776484};
GN   Name=khpB {ECO:0000255|HAMAP-Rule:MF_00867};
GN   Synonyms=eloR {ECO:0000255|HAMAP-Rule:MF_00867,
GN   ECO:0000303|PubMed:28710862}, jag {ECO:0000303|PubMed:27776484};
GN   OrderedLocusNames=spr1851;
OS   Streptococcus pneumoniae (strain ATCC BAA-255 / R6).
OC   Bacteria; Firmicutes; Bacilli; Lactobacillales; Streptococcaceae;
OC   Streptococcus.
OX   NCBI_TaxID=171101;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC BAA-255 / R6;
RX   PubMed=11544234; DOI=10.1128/jb.183.19.5709-5717.2001;
RA   Hoskins J., Alborn W.E. Jr., Arnold J., Blaszczak L.C., Burgett S.,
RA   DeHoff B.S., Estrem S.T., Fritz L., Fu D.-J., Fuller W., Geringer C.,
RA   Gilmour R., Glass J.S., Khoja H., Kraft A.R., Lagace R.E., LeBlanc D.J.,
RA   Lee L.N., Lefkowitz E.J., Lu J., Matsushima P., McAhren S.M., McHenney M.,
RA   McLeaster K., Mundy C.W., Nicas T.I., Norris F.H., O'Gara M., Peery R.B.,
RA   Robertson G.T., Rockey P., Sun P.-M., Winkler M.E., Yang Y.,
RA   Young-Bellido M., Zhao G., Zook C.A., Baltz R.H., Jaskunas S.R.,
RA   Rosteck P.R. Jr., Skatrud P.L., Glass J.I.;
RT   "Genome of the bacterium Streptococcus pneumoniae strain R6.";
RL   J. Bacteriol. 183:5709-5717(2001).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, DOMAIN, PHOSPHORYLATION AT
RP   THR-89, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF THR-89.
RC   STRAIN=Rx1;
RX   PubMed=27776484; DOI=10.1186/s12866-016-0865-6;
RA   Ulrych A., Holeckova N., Goldova J., Doubravova L., Benada O.,
RA   Kofronova O., Halada P., Branny P.;
RT   "Characterization of pneumococcal Ser/Thr protein phosphatase phpP mutant
RT   and identification of a novel PhpP substrate, putative RNA binding protein
RT   Jag.";
RL   BMC Microbiol. 16:247-247(2016).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, PHOSPHORYLATION, DISRUPTION
RP   PHENOTYPE, AND MUTAGENESIS OF THR-89; 228-TYR-HIS-229 AND 297-ARG--HIS-301.
RC   STRAIN=R6 / R704;
RX   PubMed=28710862; DOI=10.1111/mmi.13748;
RA   Stamsaas G.A., Straume D., Ruud Winther A., Kjos M., Frantzen C.A.,
RA   Haavarstein L.S.;
RT   "Identification of EloR (Spr1851) as a regulator of cell elongation in
RT   Streptococcus pneumoniae.";
RL   Mol. Microbiol. 105:954-967(2017).
RN   [4]
RP   FUNCTION, INTERACTION WITH KHPA, SUBUNIT, DOMAIN, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF LEU-239.
RC   STRAIN=R6 / R704;
RX   PubMed=30842445; DOI=10.1038/s41598-018-38386-6;
RA   Winther A.R., Kjos M., Stamsaas G.A., Haavarstein L.S., Straume D.;
RT   "Prevention of EloR/KhpA heterodimerization by introduction of site-
RT   specific amino acid substitutions renders the essential elongasome protein
RT   PBP2b redundant in Streptococcus pneumoniae.";
RL   Sci. Rep. 9:3681-3681(2019).
RN   [5]
RP   INTERACTION WITH MLTG; RODZ AND YIDC2, SUBCELLULAR LOCATION, AND DOMAIN.
RC   STRAIN=R6 / R704;
RX   PubMed=33558392; DOI=10.1128/jb.00691-20;
RA   Winther A.R., Kjos M., Herigstad M.L., Haavarstein L.S., Straume D.;
RT   "EloR interacts with the lytic transglycosylase MltG at midcell in
RT   Streptococcus pneumoniae R6.";
RL   J. Bacteriol. 0:0-0(2021).
CC   -!- FUNCTION: A probable RNA chaperone. Forms a complex with KhpA which
CC       binds to cellular RNA and controls its expression. Plays a role in
CC       peptidoglycan (PG) homeostasis and cell length regulation.
CC       {ECO:0000255|HAMAP-Rule:MF_00867}.
CC   -!- FUNCTION: Forms a complex with KhpA which stimulates or controls
CC       elongasome-mediated lateral cell wall biosynthesis (PubMed:30842445).
CC       RNA-bonding protein; overexpression leads to cell elongation,
CC       suggesting it plays a role in cell division and maintenance of cell
CC       shape (PubMed:27776484). In cell elongation the phosphorylated form
CC       activates cell elongation while the non-phosphorylated form is less
CC       active or inactive (Probable). Probably plays a role in regulation of
CC       other RNAs (By similarity). {ECO:0000250|UniProtKB:A0A0H2ZPS7,
CC       ECO:0000269|PubMed:27776484, ECO:0000269|PubMed:30842445,
CC       ECO:0000305|PubMed:28710862}.
CC   -!- SUBUNIT: Interacts with StkP which phosphorylates it (PubMed:27776484,
CC       PubMed:28710862). Interacts with KhpA via the KH domain of this protein
CC       (PubMed:30842445). Interacts with MreC in the elongasome
CC       (PubMed:28710862). Interacts with MltG, RodZ and YidC2, interacts with
CC       MltG's N-terminus (PubMed:33558392). {ECO:0000269|PubMed:27776484,
CC       ECO:0000269|PubMed:28710862, ECO:0000269|PubMed:30842445,
CC       ECO:0000269|PubMed:33558392}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00867,
CC       ECO:0000305|PubMed:28710862}. Note=Localizes to midcell in the septal
CC       area; some protein remains in the cytoplasm.
CC       {ECO:0000269|PubMed:28710862, ECO:0000269|PubMed:33558392}.
CC   -!- DOMAIN: Has an N-terminal Jag-N, a linker with a phosphorylated Thr,
CC       and 2 RNA-binding domains (KH and R3H) (Probable). A phosphomimetic
CC       mutation and mutations that prevent nucleic acid binding are not
CC       tolerated in strain R6 (PubMed:28710862). The KH domain of this protein
CC       interacts with KhpA (PubMed:30842445). The Jag-N domain is responsible
CC       for targeting to the midcell (PubMed:33558392).
CC       {ECO:0000269|PubMed:28710862, ECO:0000269|PubMed:30842445,
CC       ECO:0000269|PubMed:33558392, ECO:0000305|PubMed:27776484,
CC       ECO:0000305|PubMed:28710862}.
CC   -!- PTM: Phosphorylated on Thr-89 by StkP; there is another phosphorylated
CC       Thr residue in the protein, which is more strongly phosphorylated in
CC       strain R6 than in Rx1 (PubMed:27776484, PubMed:28710862).
CC       Dephosphorylated by PhpP (PubMed:27776484). Phosphorylation is
CC       increased in an R6 strain with a C-terminal MreC deletion
CC       (PubMed:28710862). {ECO:0000269|PubMed:27776484,
CC       ECO:0000269|PubMed:28710862}.
CC   -!- DISRUPTION PHENOTYPE: Grows more slowly with a longer lag phase and
CC       decreased final density compared to wild-type. Cells are significantly
CC       smaller (PubMed:27776484, PubMed:28710862). Suppresses deletions of
CC       PBP2b (penA). Double penA-khpB or rodA-khpB deletions partially
CC       alleviate the slow growth phenotype of the single deletion
CC       (PubMed:28710862). KhpA is no longer targeted to midcell
CC       (PubMed:30842445). {ECO:0000269|PubMed:27776484,
CC       ECO:0000269|PubMed:28710862, ECO:0000269|PubMed:30842445}.
CC   -!- MISCELLANEOUS: Strain Rx1 is unencapsulated.
CC       {ECO:0000305|PubMed:27776484}.
CC   -!- SIMILARITY: Belongs to the KhpB RNA-binding protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_00867}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE007317; AAL00654.1; -; Genomic_DNA.
DR   PIR; A99703; A99703.
DR   PIR; H95238; H95238.
DR   RefSeq; NP_359443.1; NC_003098.1.
DR   RefSeq; WP_000260012.1; NC_003098.1.
DR   AlphaFoldDB; Q8CY87; -.
DR   STRING; 171101.spr1851; -.
DR   EnsemblBacteria; AAL00654; AAL00654; spr1851.
DR   GeneID; 60233791; -.
DR   KEGG; spr:spr1851; -.
DR   PATRIC; fig|171101.6.peg.1997; -.
DR   eggNOG; COG1847; Bacteria.
DR   HOGENOM; CLU_042512_0_0_9; -.
DR   OMA; INQKHAP; -.
DR   Proteomes; UP000000586; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   CDD; cd02414; jag_KH; 1.
DR   CDD; cd02644; R3H_jag; 1.
DR   Gene3D; 3.30.1370.50; -; 1.
DR   Gene3D; 3.30.30.80; -; 1.
DR   Gene3D; 3.30.300.20; -; 1.
DR   HAMAP; MF_00867; KhpB; 1.
DR   InterPro; IPR038008; Jag_KH.
DR   InterPro; IPR038247; Jag_N_dom_sf.
DR   InterPro; IPR015946; KH_dom-like_a/b.
DR   InterPro; IPR039247; KhpB.
DR   InterPro; IPR032782; KhpB_N.
DR   InterPro; IPR001374; R3H_dom.
DR   InterPro; IPR036867; R3H_dom_sf.
DR   InterPro; IPR034079; R3H_KhpB.
DR   PANTHER; PTHR35800; PTHR35800; 1.
DR   Pfam; PF14804; Jag_N; 1.
DR   Pfam; PF01424; R3H; 1.
DR   SMART; SM01245; Jag_N; 1.
DR   SMART; SM00393; R3H; 1.
DR   SUPFAM; SSF82708; SSF82708; 1.
DR   PROSITE; PS51061; R3H; 1.
PE   1: Evidence at protein level;
KW   Cell shape; Cell wall biogenesis/degradation; Chaperone; Cytoplasm;
KW   Phosphoprotein; Reference proteome; RNA-binding.
FT   CHAIN           1..328
FT                   /note="RNA-binding protein KhpB"
FT                   /id="PRO_0000454544"
FT   DOMAIN          181..258
FT                   /note="KH"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00867,
FT                   ECO:0000305|PubMed:27776484, ECO:0000305|PubMed:28710862"
FT   DOMAIN          263..328
FT                   /note="R3H"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00867,
FT                   ECO:0000305|PubMed:27776484, ECO:0000305|PubMed:28710862"
FT   REGION          3..53
FT                   /note="Jag_N domain"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_00867,
FT                   ECO:0000305|PubMed:27776484, ECO:0000305|PubMed:28710862"
FT   REGION          54..180
FT                   /note="Linker"
FT                   /evidence="ECO:0000305|PubMed:27776484,
FT                   ECO:0000305|PubMed:28710862"
FT   MOD_RES         89
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:27776484"
FT   MUTAGEN         89
FT                   /note="T->A: Nearly complete loss of phosphothreonine
FT                   (strain Rx1), loss of 1 phosphothreonine (in strain R6). In
FT                   R6 cells are significantly smaller."
FT                   /evidence="ECO:0000269|PubMed:27776484,
FT                   ECO:0000269|PubMed:28710862"
FT   MUTAGEN         89
FT                   /note="T->E: Can only be found in strain R6 cells when mreC
FT                   or rodZ acquire suppressor mutations; cells are
FT                   significantly smaller."
FT                   /evidence="ECO:0000269|PubMed:28710862"
FT   MUTAGEN         228..229
FT                   /note="YH->DD: Can only be found in strain R6 cells when
FT                   rodZ acquires suppressor mutations; cells are significantly
FT                   smaller."
FT                   /evidence="ECO:0000269|PubMed:28710862"
FT   MUTAGEN         239
FT                   /note="L->Y: Loss of interaction with KhpA, pbp2b can be
FT                   deleted, KphA not found at midcell."
FT                   /evidence="ECO:0000269|PubMed:30842445"
FT   MUTAGEN         297..301
FT                   /note="RKIIH->KKIIY: Can only be found in strain R6 cells
FT                   when mreC acquires suppressor mutations; cells are
FT                   significantly smaller."
FT                   /evidence="ECO:0000269|PubMed:28710862"
SQ   SEQUENCE   328 AA;  37110 MW;  162BBC1B10CDC109 CRC64;
     MVVFTGSTVE EAIQKGLKEL DIPRMKAHIK VISREKKGFL GLFGKKPAQV DIEAISETTV
     VKANQQVVKG VPKKINDLNE PVKTVSEETV DLGHVVDAIK KIEEEGQGIS DEVKAEILKH
     ERHASTILEE TGHIEILNEL QIEEAMREEA GADDLETEQD QAESQELEDL GLKVETNFDI
     EQVATEVMAY VQTIIDDMDV EATLSNDYNR RSINLQIDTN EPGRIIGYHG KVLKALQLLA
     QNYLYNRYSR TFYVTINVND YVEHRAEVLQ TYAQKLATRV LEEGRSHKTD PMSNSERKII
     HRIISRMDGV TSYSEGDEPN RYVVVDTE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024